H. Lundbeck, Ebixa®, extended approval for the treatment of moderate Alzheimer’s disease
At a meeting held on 10-13 October 2005, the European health authorities approved Ebixa® (memantine) for the treatment of moderate Alzheimer’s disease.
At a meeting held on 10-13 October 2005, the European health authorities approved Ebixa® (memantine) for the treatment of moderate Alzheimer’s disease.